Should patients with haemophilia receive gene therapy?

VandenDriessche, Thierry; Tatsumi, Kohei; Shima, Midori

VandenDriessche, Thierry; Tatsumi, Kohei; Shima, Midori.

Afiliação

VandenDriessche T; Vrije Universiteit Brussel, Brussels, Belgium; University of Leuven, Leuven, Belgium. Electronic address: thierry.vandendriessche@vub.be.
Tatsumi K; Thrombosis and Hemostasis Research Center, Nara Medical University, Nara, Japan.
Shima M; Thrombosis and Hemostasis Research Center, Nara Medical University, Nara, Japan. Electronic address: mshima@naramed-u.ac.jp.

Lancet Haematol ; 9(10): e722-e723, 2022 10.

Article em En | MEDLINE | ID: mdl-36174639

Assuntos

Hemofilia A; Terapia Genética; Hemofilia A/genética; Hemofilia A/terapia; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemofilia A Limite: Humans Idioma: En Revista: Lancet Haematol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google